Evgen Pharma is a clinical stage drug development company focused on cancer and neurological disease. Their objective is to use Sulforadex® technology to turn this scientific promise into commercially successful products, addressing important clinical needs.

Annual Report 2020

The annual report is simple in its design and focuses on giving the reader an understanding of the huge potential in the Company’s chosen markets as well as presenting the success of the Company to date in the marketing and further development of its unique clinical research.